Low molecular weight heparin vs control
- Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children 2020 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 813 participantsLow
Retrievable vena caval filters with anticoagulation showed no clear difference in PE: recurrent fatal and non‐fatal PE, demonstrated by CT, pulmonary… compared with anticoagulation (moderate certainty).
Retrievable vena caval filters with anticoagulation showed no clear difference in mortality (up to 6 months) compared with anticoagulation (moderate certainty).
Retrievable vena caval filters with anticoagulation showed no clear difference in symtomatic lower extremity venous thrombosis confirmed by Doppler… compared with anticoagulation (moderate certainty).
Retrievable vena caval filters with anticoagulation showed no clear difference in major bleedingc (up to 6 months) compared with anticoagulation (moderate certainty).
It is very uncertain whether atherectomy changes primary patency ( compared with balloon angioplasty (very low certainty).
It is very uncertain whether atherectomy changes mortality ( compared with balloon angioplasty with primary stenting (very low certainty).
It is very uncertain whether atherectomy changes fatal and non‐fatal cardiovascular events ( compared with balloon angioplasty with primary stenting (very low certainty).
It is very uncertain whether atherectomy changes TVR ( compared with balloon angioplasty with primary stenting (very low certainty).
It is very uncertain whether atherectomy changes complication rates ( compared with balloon angioplasty with primary stenting (very low certainty).
It is very uncertain whether atherectomy changes mortality ( compared with balloon angioplasty (very low certainty).
It is very uncertain whether atherectomy changes TVR ( compared with balloon angioplasty (very low certainty).
It is very uncertain whether atherectomy changes complication rates ( compared with balloon angioplasty (very low certainty).